Sunday, December 8, 2019

Latest:

Why Houston isn’t immune from the opioid epidemic
Immune checkpoint therapy for ER+ breast cancers, a missed opportunity?
Fighting lung cancer: How new therapies are improving outcomes
Celebrate the holidays with these guilt-free treats
Top six most viewed Images of the Month, 2019

Baylor College of Medicine Blog Network

Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
PolicyWise
- About PolicyWise
- Follow @BCMEthics on Twitter
Progress Notes
- About Progress Notes
- Connect With Us
bcm.edu

neratinib

From The Labs

A new HER2 mutation leads to a clinical trial and to a promising diagnostic tool for metastatic breast cancer

July 27, 2017 Ana Rodríguez 0 Comments circulating tumor DNA, clinical trial, HER2 gene, Metastatic breast cancer, neratinib

There is a group of metastatic breast cancers that has the HER2 gene amplified – the cells have many copies

From the Labs wraps up the Image of the Month feature for the year by presenting a slideshow with the top six most viewed images in 2019.

Listen to the Body of Work Podcast

Body of Work, the Baylor College of Medicine podcast, is an exploration of health topics in the news and important scientific matters featuring insights from experts at Baylor. Listen on your preferred platform.